Genie L. Bailey

发表

Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.

M. Stein, B. Anderson, Shannon R Kenney, 2019, Journal of substance abuse treatment.

Drug Use-Related Normative Misperceptions and Behaviors Among Persons Seeking Heroin Withdrawal Management.

M. Stein, B. Anderson, Shannon R Kenney, 2019, Journal of addiction medicine.

Group therapy for women with substance use disorders: results from the Women's Recovery Group Study.

Dawn E. Sugarman, G. Fitzmaurice, Genie L. Bailey, 2014, Drug and alcohol dependence.

Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

M. Stein, B. Anderson, Shannon R Kenney, 2020, Journal of substance abuse treatment.

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

B. Haight, M. Greenwald, S. Segal, 2019, The Lancet.

Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial.

Udi E. Ghitza, U. Ghitza, Mei-Chen Hu, 2017, Addictive behaviors.

Expected and actual fentanyl exposure among persons seeking opioid withdrawal management.

M. Stein, B. Anderson, Shannon R Kenney, 2018, Journal of substance abuse treatment.

Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

L. Tamm, P. Nakonezny, T. Winhusen, 2013, Journal of substance abuse treatment.

Expectations about alcohol, cocaine, and benzodiazepine abstinence following inpatient heroin withdrawal management

M. Stein, B. Anderson, Shannon R Kenney, 2018, The American journal on addictions.

A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.

A. Abrantes, G. Tremont, Genie L. Bailey, 2019, Journal of substance abuse treatment.

Initiating buprenorphine treatment for opioid use disorder during short-term in-patient 'detoxification': a randomized clinical trial.

B. Anderson, Genie L. Bailey, D. Herman, 2019, Addiction.

Predicting Treatment Response in Adolescents with ADHD Who Use Substances

L. Tamm, R. Barkley, P. Nakonezny, 2013 .

Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.

M. Stein, B. Anderson, Shannon R Kenney, 2017, Journal of substance abuse treatment.

Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.

A. Abrantes, M. Stein, B. Anderson, 2019, The American journal on addictions.

Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

R. Weisberg, M. Stein, Genie L. Bailey, 2015, Pain medicine.

Comparing the life concerns of prescription opioid and heroin users.

M. Stein, B. Anderson, Genie L. Bailey, 2015, Journal of substance abuse treatment.

Factors associated with naloxone administration in an opioid dependent sample.

M. Stein, B. Anderson, Shannon R Kenney, 2018, Journal of substance abuse treatment.

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

E. Nunes, J. Rotrosen, R. Lindblad, 2017, The Lancet.

Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study.

Genie L. Bailey, M. Crisafulli, S. Greenfield, 2013, The American journal on addictions.

Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder

E. Nunes, J. Strang, P. Haber, 2019, Addiction.

Comparative e ff ectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention ( X : BOT ) : a multicentre , open-label , randomised controlled trial

E. Nunes, D. Stablein, J. Rotrosen, 2018 .

Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine.

M. Stein, B. Anderson, Genie L. Bailey, 2021, Journal of substance abuse treatment.

Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.

R. Rosenthal, W. Ling, A. Patkar, 2013, Addiction.

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.

R. Rosenthal, W. Ling, G. Bigelow, 2010, JAMA.